Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Acquisition

27 Jan 2015 07:01

RNS Number : 1870D
Kingspan Group PLC
27 January 2015
 

Kingspan Group plc

 

Acquisition

 

 

27 January 2015

 

Kingspan Group plc ("Kingspan") announces the acquisition of Joris Ide Group

 

Kingspan, the global leader in high performance insulation and building envelopes, is pleased to announce that it has entered into an agreement with Ergon Capital Partners II NV and Bremhove NV, to acquire 100% of the shares of Steel Partners NV, the holding company of the Joris Ide Group ("Joris Ide").

 

Joris Ide is a pan European manufacturer and supplier of insulated panels, profiles and related accessories, with leading market positions in France and the Benelux. It has 5 insulated panel manufacturing facilities in Belgium, Germany, Romania and Russia, and 11 regional manufacturing sites across Europe, which provide a uniquely complementary geographic footprint to Kingspan's existing European insulated panel business.

 

The consideration for the business will be circa EUR315m inclusive of debt, which will vary depending on the specific amount of working capital and debt on completion. The consideration will be satisfied on completion partly in cash and by the assumption of debt, with the balance of the consideration satisfied by the issue of three million shares in Kingspan Group plc to Bremhove NV, which is the holding company of the founder and major shareholder Mr Joris Ide.

 

In the 12 months to 31 December 2014, Joris Ide had unaudited revenues of EUR465m and EBITDA of EUR36m. Revenues and adjusted EBITDA to 31 December 2013 were EUR435m and EUR28m respectively. As at 31 December 2013, Joris Ide had gross assets of EUR316m, and on completion net assets excluding goodwill are expected to be EUR135m. The acquisition is expected to enhance earnings by circa 7 cent on a fully annualised basis.

 

The existing management team of Joris Ide will be retained in the business, and will continue to manage and develop the business distinct from the Kingspan brand. The acquisition is conditional on regulatory clearance, and is expected to complete towards the end of the first quarter of 2015.

 

Kingspan also announces that it has negotiated EUR127.5m private placement loan notes with weighted average maturities of 8 years. The weighted average coupon on the new notes is 1.92%. The proceeds will be primarily used to repay private placement loan notes which are due to mature in March 2015. Kingspan has also negotiated additional bilateral facilities of EUR190m. These facilities, together with cash and drawings from the previously undrawn Revolving Credit Facility, will be used to fund the Joris Ide and previously announced Vicwest acquisitions.

 

Gene Murtagh, Kingspan Chief Executive Officer, commented:

 

"The acquisition of Joris Ide Group represents a quantum leap forward in the execution of our strategy to fully globalise Kingspan. It takes us into a distinctly different tier in the market than typically occupied by the Kingspan branded products, and with its operations in Belgium, France, Germany, Romania and Russia significantly extends the reach of our Group."

 

Kingspan will hold an analysts' call at 8.30 GMT on 27 January 2015 to discuss the acquisition. A recording of this conference call will be available from 10.00 GMT on 27 January 2015 and full details of the number to call will be available on our website. For further information about the conference call please contact: julie.shankey@kingspan.com or +353 (0)42 969 8016.

 

 

 

For further information contact:

 

 

Kingspan

Gene Murtagh/Geoff Doherty

 

+353 42 9698000

Murray Consultants

Douglas Keatinge

+353 1 4980300

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEANFKASSSEFF
Date   Source Headline
1st Nov 20193:33 pmRNSTotal Voting Rights
1st Oct 20193:31 pmRNSTotal Voting Rights
24th Sep 20195:38 pmRNSHolding(s) in Company
17th Sep 20195:41 pmRNSHolding(s) in Company
2nd Sep 20191:04 pmRNSTotal Voting Rights
23rd Aug 20197:00 amRNSHalf-year Report
23rd Aug 20197:00 amRNSEuronext Dublin Market Notice
22nd Aug 20193:13 pmRNSHolding(s) in Company
19th Aug 20193:00 pmRNSBlock Listing Application
8th Aug 20199:22 amRNSHolding(s) in Company
11th Jul 20193:38 pmRNSHolding(s) in Company
1st Jul 20195:35 pmRNSBlock listing Interim Review
1st Jul 20193:14 pmRNSTotal Voting Rights
1st Jul 201910:41 amRNSCorporate Broker Appointment
19th Jun 20193:57 pmRNSDirector/PDMR Shareholding
18th Jun 20195:25 pmRNSDirector/PDMR Shareholding
5th Jun 20194:52 pmRNSDirector/PDMR Shareholding
4th Jun 20191:04 pmRNSTotal Voting Rights
4th Jun 201910:33 amRNSHolding(s) in Company
21st May 201910:30 amRNSDirector/PDMR Shareholding
20th May 20197:00 amRNSHolding(s) in Company - REPLACEMENT
17th May 20194:20 pmRNSDirector/PDMR Shareholding
17th May 20194:16 pmRNSHolding(s) in Company
9th May 20195:46 pmRNSDirector/PDMR Shareholding
9th May 20195:46 pmRNSDirector Declaration
7th May 20195:07 pmRNSResult of AGM
7th May 20193:42 pmRNSDirector/PDMR Shareholding
3rd May 20197:00 amRNSAGM Statement
1st May 201910:37 amRNSTotal Voting Rights
26th Apr 20197:15 amRNSStatement re Recticel NV/SA
16th Apr 201910:15 amRNSStatement re Recticel NV/SA
1st Apr 20195:13 pmRNSTotal Voting Rights
27th Mar 20194:40 pmRNSHolding(s) in Company
27th Mar 20192:39 pmRNSDirector/PDMR Shareholding
19th Mar 201910:27 amRNSHolding(s) in Company
14th Mar 201912:36 pmRNSDirector/PDMR Shareholding
13th Mar 201910:01 amRNSChange of Adviser
5th Mar 201912:30 pmRNSAnnual Financial Report
4th Mar 20193:52 pmRNSHolding(s) in Company
1st Mar 20194:16 pmRNSTotal Voting Rights
26th Feb 20199:45 amRNSDirector/PDMR Shareholding
22nd Feb 20197:00 amRNSFinal Results
18th Feb 201911:22 amRNSHolding(s) in Company
14th Feb 20195:43 pmRNSHolding(s) in Company
8th Feb 20193:02 pmRNSHolding(s) in Company
4th Feb 20194:27 pmRNSHolding(s) in Company
23rd Jan 20195:35 pmRNSHolding(s) in Company
11th Jan 201912:51 pmRNSHolding(s) in Company
2nd Jan 201910:30 amRNSBlock listing Interim Review
2nd Jan 201910:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.